Unique microbial technologies for the production of pharmaceutical proteins

Wacker Biotech a Europe-wide leader with the production of bacterial biologics

The biotechnology company Wacker Biotech GmbH is a contract producer of pharmaceutical proteins. Its areas of business include molecular biology, analysis and process development as well as the production of active pharmaceutical agents for clinical studies. In the city of Halle in the German federal state of Saxony-Anhalt, WACKER is also producing an active pharmaceutical agent for a previously approved drug to treat heart disease.

WACKER ascertained the long term importance of bacterial systems at an early stage. Click here to read the full article: ​http://lsaurl.de/Vayi


Wacker Biotech is based in the German federal state of Saxony-Anhalt, a location that provides excellent conditions for research and development and the right financial instruments. Wacker Biotech is only one of several flagship companies representing Saxony-Anhalt's competence in biotechnology and pharmaceuticals at BIO International Convention 2016 in San Francisco.

Meet us at booth 1005-03, in the German Pavilion, at BIO 2016 and get to know ​G​ermany's biotech region Saxony-Anhalt.

Frauke Flenker-Manthey
Press Officer
Investment and Marketing Corporation Saxony-Anhalt
Am Alten Theater 6
39104 Magdeburg
Tel.: 0049 (0) 391-567 7076
Fax.: 0049 (0) 391-567 7081
E-Mail: flenker-manthey@img-sachsen-anhalt.de

Investment and Marketing Corporation Saxony-Anhalt (IMG)

IMG is the economic development agency of the German federal state Saxony-Anhalt. IMG staff provides all services related to new business sites. In addition, we are marketing Saxony-Anhalt both nationally and internationally and developing tourism concepts.
We search our site and property database with 250 industrial and trade estates for a location tailored to your needs. We provide competent and individual advice for greenfield and brownfield sites, office properties or production halls. First site information provided within 24 hours. Arrangement of site visits take place following your preliminary selection. We can advise you on public grant programmes for investments, identify potential partners and arrange meetings with them. We identify a point of contact for you with the public authorities, coordinate and carry out negotiations for you on a federal state, state district and municipal level as well as with official bodies and institutions. We were assigned by the Ministry for Science and Economic Affairs of Saxony-Anhalt to guide you as a one-stop agency through the investment process.
Our services are free of charge for you!
For the second time in succession IMG has been awarded with the “Best to Invest - Top Investment Promotion Agency Award" as one the best regional economic development agencies in Europe.





Until 2020, the global market for biopharmaceuticals is set to grow by an average rate of nine percent and a volume of about 280 billion US dollars.
Sebastian Schuck, Manager of the Business Development department at Wacker Biotech GmbH